A new drug called mipomersen reduced low–density lipoprotein "bad" cholesterol by nearly 25 percent when added to current therapy in people with a rare genetic condition that causes extremely high cholesterol, a new study finds. Inherited high cholesterol affects one in every one million people. Patients with the disorder have severely elevated LDL cholesterol and a high risk of early cardiovascular disease. If untreated, these patients rarely live past the age of 30. ... Click Here to Read More Click Here to Read More
